Trial intelligence / Profile preview

Nebivolol vs bisoprolol in mild to moderate primary hypertension

CTR20140869Phase 3Active

Sponsor
Ventmed
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nebivolol in essential hypertension, sponsored by Ventmed. Started Dec 2014; status: active.

02

Drugs

nebivolol
03

Conditions

essential hypertension

Beyond the preview

Go deeper on CTR20140869.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140869.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call